Research indicates that plasma IL-8 levels in patients with sustained severe AKI may serve as effective biomarkers for predicting early postsurgical AKI (PS-AKI) in COVID-19 patients and are useful for forecasting the onset of AKI after cardiopulmonary bypass (CPB) surgery [66]. The gene discussed is CXCL8; the disease is acute kidney injury.